No black box warning on record for Butal/apap/caffeine

As of the latest FDA labeling reviewed, Butal/apap/caffeine (BUTAL/APAP/CAFFEINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Butal/apap/caffeine medicine page for the complete safety profile.

Other warnings & precautions

Hepatotoxicity Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen-containing product. The excessive intake of acetaminophen may be intentional to cause self-harm

No black box warning on record for Butal/apap/caffeine

Other warnings & precautions

Hepatotoxicity Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen-containing product. The excessive intake of acetaminophen may be intentional to cause self-harm

Butal/apap/caffeine Black Box Warning

No black box warning on record for Butal/apap/caffeine

Other warnings & precautions

Butal/apap/caffeine Black Box Warning

No black box warning on record for Butal/apap/caffeine

Other warnings & precautions